Bulletin
Investor Alert

New York Markets Open in:

SQZ Biotechnologies Co.

NYS: SQZ

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Jan 27, 2022, 4:10 p.m.

SQZ
/zigman2/quotes/222210446/composite

$

6.34

Change

-0.73 -10.33%

Volume

Volume 61,605

Quotes are delayed by 20 min

/zigman2/quotes/222210446/composite

Previous close

$ 7.07

$ 6.34

Change

-0.73 -10.33%

Day low

Day high

$6.29

$7.11

Open

52 week low

52 week high

$6.29

$29.34

Open

Annual Financials for SQZ Biotechnologies Co.

Fiscal year is January-December. All values USD millions. 201820192020 5-year trend
Sales/Revenue --12.67M20.11M21M
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense --1.07M4.36M10.94M
Depreciation --1.07M4.36M10.94M
Amortization of Intangibles -----
Gross Income -----
201820192020 5-year trend
SG&A Expense --32.01M50.02M61.11M
Research & Development --24.38M36.1M51.55M
Other SG&A --7.63M13.92M9.57M
Other Operating Expense -----
Unusual Expense -----
EBIT after Unusual Expense -----
Non Operating Income/Expense --176,000(7,000)(13,000)
Non-Operating Interest Income --978,0002.07M550,000
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income --(19.25M)(32.2M)(50.52M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) --(984,000)--
Consolidated Net Income --(20.23M)(32.2M)(50.52M)
Minority Interest Expense -----
Net Income --(20.23M)(32.2M)(50.52M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries --(20.23M)(32.2M)(50.52M)
Preferred Dividends -----
Net Income Available to Common --(20.23M)(32.2M)(50.52M)
EPS (Basic) --(0.82)(1.31)(2.04)
Basic Shares Outstanding --24.63M24.63M24.79M
EPS (Diluted) --(0.82)(1.31)(2.04)
Diluted Shares Outstanding --24.63M24.63M24.79M
EBITDA --(19.34M)(29.91M)(40.12M)
Trending Tickers
  • /zigman2/quotes/207732364/composite MSFT-2.66%
  • /zigman2/quotes/203165245/composite T+0.53%
  • /zigman2/quotes/213120645/composite DKNG-3.54%
  • /zigman2/quotes/209901640/composite SPY-1.22%
  • /zigman2/quotes/209958550/composite AUPH+3.30%
X
Powered by StockTwits
Link to MarketWatch's Slice.